A new study showed that aspirin use was associated with a 47% reduction in the risk of dying in hospital due to: COVID-19.
According to the study published on the site ” thehealthsiteCorona-19 patients who were taking aspirin showed fewer chances of needing to be placed in the intensive care unit (ICU) From those who did not take aspirin.
Corona patients, who were taking aspirin, were not required to be under ventilation, and were more like surviving the infection compared to those who did not take aspirin.
According to the researchers, this is an important finding that needs confirmation through a randomized clinical trial, so if this finding is confirmed, it will be Aspirin The first drug widely available without a prescription to reduce deaths in patients COVID-19.
Aspirin and Coronavirus –
Study: Reduces Mortality Risk by 47%
To conduct the study, the research team examined the medical records of 412 patients from Covid-19 , Whose average age is 55 years old, who have been hospitalized over the past few months due to complications from their injury.
Nearly a quarter of patients were taking a daily low dose of aspirin (usually 81 milligrams) before or immediately after admission, to control cardiovascular disease.
Researchers found that aspirin use was associated with a 44% reduction in the risk of exposure to a ventilator, a 43% reduction in the risk of being admitted to the ICU, and most importantly – a 47% reduction in the risk of dying in hospital compared to those who did not take aspirin.
Patients in the aspirin group did not experience a significant increase in adverse events such as heavy bleeding during hospitalization.
The results of the study showed that the risk of needing mechanical ventilation for difficulty breathing was 35.7% in patients who took aspirin, while it was 48.4% in non-aspirin patients, while the risk of admission to intensive care units was (ICUs) 38.8 % In patients who took aspirin, while it was 51.0% in patients who did not use aspirin.
However, research has also highlighted that daily use of aspirin can also increase the risk of major bleeding or peptic ulcer disease. According to them, the blood-thinning effects of aspirin provide benefits to patients COVID-19 By preventing the formation of micro clots.
People at risk of bleeding due to chronic kidney disease, for example, or because they regularly use certain medications, such as steroids or blood thinners, may not be able to safely take aspirin.
However, more research is needed to confirm the link between aspirin use and its effect on lung injury and infection-related deaths COVID-19.
– .
